NCT00199771View on ClinicalTrials.gov

Hypertonic Saline Dextran in Pediatric Cardiac Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

February 28, 2005

Conditions

Heart Defects, CongenitalTransposition of Great VesselsHeart Septal Defects, VentricularEndocardial Cushion Defects

Interventions

DRUG

7.5% NaCl in 6% dextran 70 solution

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

BioPhausia

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT00199771 - Hypertonic Saline Dextran in Pediatric Cardiac Surgery | Biotech Hunter | Biotech Hunter